Gladstone in the News
December 3, 2023
Genetic Engineering & Biotechnology News—In addition to genetic changes, environmental factors are associated with the development of birth defects. A new study led by Deepak Srivastava, president of Gladstone Institutes, reveals how maternal diabetes alters a small subset of cells in the developing heart in a way that can lead to congenital heart defects.
Gladstone Experts
Congenital Heart Disease
Diabetes
Cardiovascular Disease
Srivastava Lab
Single Cell
Article
January 17, 2017
Anti-cancer drug prevented less weight gain and caused mice to burn more calories thanks to higher levels of metabolism-boosting brown fat.
Ding Lab
Metabolism
Diabetes
Article
January 5, 2016
Scientists at the Gladstone Institutes have successfully converted human skin cells into fully-functional pancreatic cells.
Diabetes
Ding Lab
Stem Cells/iPSCs
Article
April 27, 2015
Finding could have implications for other autoimmune disorders, such as type I diabetes.
Multiple Sclerosis
Diabetes
Article
June 20, 2014
With his unique combination of biology and chemistry, Gladstone’s Sheng Ding is quickly becoming a tour-de-force in the field of regenerative medicine.
Ding Lab
Stem Cells/iPSCs
Diabetes
Article
February 6, 2014
A cure for type 1 diabetes has long eluded even the top experts. Not because they do not know what must be done—but because the tools did not exist to do it.
Diabetes
Ding Lab
Stem Cells/iPSCs
March 27, 2012
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have discovered a key protein that regulates insulin resistance—the diminished ability of cells to respond to the action of insulin and which sets the stage for the development of the most common form of diabetes.
Akassoglou Lab
Diabetes
Metabolism
August 17, 2011
SAN FRANCISCO, CA—A scientist at the Gladstone Institutes has discovered how a gene known as SIRT3 contributes to a suite of health problems sweeping across America, offering new insight into how to combat these potentially fatal conditions.
Diabetes
Metabolism